HEADER LYASE 10-AUG-20 7A0T TITLE CRYSTAL STRUCTURE OF KIEVITONE HYDRATASE FROM NECTRIA HAEMATOCOCCA TITLE 2 (P21 SG) COMPND MOL_ID: 1; COMPND 2 MOLECULE: CRTC DOMAIN-CONTAINING PROTEIN; COMPND 3 CHAIN: A, B; COMPND 4 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: FUSARIUM VANETTENII 77-13-4; SOURCE 3 ORGANISM_TAXID: 660122; SOURCE 4 GENE: NECHADRAFT_51190; SOURCE 5 EXPRESSION_SYSTEM: KOMAGATAELLA PASTORIS; SOURCE 6 EXPRESSION_SYSTEM_TAXID: 4922 KEYWDS KIEVITONE HYDRATASE, KIEVITONE, LYASE EXPDTA X-RAY DIFFRACTION AUTHOR T.PAVKOV-KELLER,K.GRUBER REVDAT 1 18-AUG-21 7A0T 0 JRNL AUTH T.PAVKOV-KELLER,G.STEINKELLNER,M.ENGLEDER,M.SCHUERMANN, JRNL AUTH 2 H.BLASL,H.PICHLER,K.GRUBER JRNL TITL STRUCTURAL ANALYSIS AND REACTION MECHANISM OF KIEVITONE JRNL TITL 2 HYDRATASE FROM NECTRIA HAEMATOCOCCA JRNL REF TO BE PUBLISHED JRNL REFN REMARK 1 REMARK 1 REFERENCE 1 REMARK 1 AUTH M.ENGLEDER,M.HORVAT,A.EMMERSTORFER-AUGUSTIN,T.WRIESSNEGGER, REMARK 1 AUTH 2 S.GABRIEL,G.STROHMEIER,H.WEBER,M.MULLER,I.KALUZNA,D.MINK, REMARK 1 AUTH 3 M.SCHUERMANN,H.PICHLER REMARK 1 TITL RECOMBINANT EXPRESSION, PURIFICATION AND BIOCHEMICAL REMARK 1 TITL 2 CHARACTERIZATION OF KIEVITONE HYDRATASE FROM NECTRIA REMARK 1 TITL 3 HAEMATOCOCCA. REMARK 1 REF PLOS ONE V. 13 92653 2018 REMARK 1 REFN ESSN 1932-6203 REMARK 1 DOI 10.1371/JOURNAL.PONE.0192653 REMARK 2 REMARK 2 RESOLUTION. 2.00 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : PHENIX 1.18.2_3874 REMARK 3 AUTHORS : PAUL ADAMS,PAVEL AFONINE,VINCENT CHEN,IAN REMARK 3 : DAVIS,KRESHNA GOPAL,RALF GROSSE-KUNSTLEVE, REMARK 3 : LI-WEI HUNG,ROBERT IMMORMINO,TOM IOERGER, REMARK 3 : AIRLIE MCCOY,ERIK MCKEE,NIGEL MORIARTY, REMARK 3 : REETAL PAI,RANDY READ,JANE RICHARDSON, REMARK 3 : DAVID RICHARDSON,TOD ROMO,JIM SACCHETTINI, REMARK 3 : NICHOLAS SAUTER,JACOB SMITH,LAURENT REMARK 3 : STORONI,TOM TERWILLIGER,PETER ZWART REMARK 3 REMARK 3 REFINEMENT TARGET : GEOSTD + MONOMER LIBRARY + CDL V1.2 REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.00 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 49.00 REMARK 3 MIN(FOBS/SIGMA_FOBS) : 1.360 REMARK 3 COMPLETENESS FOR RANGE (%) : 99.3 REMARK 3 NUMBER OF REFLECTIONS : 55117 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 R VALUE (WORKING + TEST SET) : 0.178 REMARK 3 R VALUE (WORKING SET) : 0.176 REMARK 3 FREE R VALUE : 0.210 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.000 REMARK 3 FREE R VALUE TEST SET COUNT : 2757 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT (IN BINS). REMARK 3 BIN RESOLUTION RANGE COMPL. NWORK NFREE RWORK RFREE REMARK 3 1 49.0000 - 5.4300 0.98 2679 141 0.1848 0.2074 REMARK 3 2 5.4300 - 4.3100 0.99 2618 138 0.1309 0.1281 REMARK 3 3 4.3100 - 3.7600 0.98 2613 138 0.1444 0.1678 REMARK 3 4 3.7600 - 3.4200 0.99 2581 136 0.1575 0.1693 REMARK 3 5 3.4200 - 3.1700 0.99 2631 138 0.1680 0.2171 REMARK 3 6 3.1700 - 2.9900 1.00 2639 139 0.1795 0.2377 REMARK 3 7 2.9900 - 2.8400 1.00 2607 138 0.1721 0.1919 REMARK 3 8 2.8400 - 2.7100 1.00 2607 137 0.1773 0.2297 REMARK 3 9 2.7100 - 2.6100 1.00 2650 139 0.1807 0.2386 REMARK 3 10 2.6100 - 2.5200 1.00 2623 138 0.1868 0.2362 REMARK 3 11 2.5200 - 2.4400 1.00 2612 138 0.1824 0.2693 REMARK 3 12 2.4400 - 2.3700 1.00 2614 138 0.1901 0.2201 REMARK 3 13 2.3700 - 2.3100 1.00 2651 139 0.2018 0.2440 REMARK 3 14 2.3100 - 2.2500 0.99 2591 136 0.2769 0.3404 REMARK 3 15 2.2500 - 2.2000 0.99 2597 137 0.2619 0.3199 REMARK 3 16 2.2000 - 2.1500 1.00 2624 138 0.2048 0.2352 REMARK 3 17 2.1500 - 2.1100 1.00 2617 138 0.2048 0.2587 REMARK 3 18 2.1100 - 2.0700 1.00 2611 137 0.2098 0.2775 REMARK 3 19 2.0700 - 2.0300 0.99 2622 138 0.2264 0.2829 REMARK 3 20 2.0300 - 2.0000 0.98 2573 136 0.2573 0.3377 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : FLAT BULK SOLVENT MODEL REMARK 3 SOLVENT RADIUS : 1.11 REMARK 3 SHRINKAGE RADIUS : 0.90 REMARK 3 K_SOL : NULL REMARK 3 B_SOL : NULL REMARK 3 REMARK 3 ERROR ESTIMATES. REMARK 3 COORDINATE ERROR (MAXIMUM-LIKELIHOOD BASED) : 0.232 REMARK 3 PHASE ERROR (DEGREES, MAXIMUM-LIKELIHOOD BASED) : 22.865 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 30.91 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 34.95 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : NULL REMARK 3 B22 (A**2) : NULL REMARK 3 B33 (A**2) : NULL REMARK 3 B12 (A**2) : NULL REMARK 3 B13 (A**2) : NULL REMARK 3 B23 (A**2) : NULL REMARK 3 REMARK 3 TWINNING INFORMATION. REMARK 3 FRACTION: NULL REMARK 3 OPERATOR: NULL REMARK 3 REMARK 3 DEVIATIONS FROM IDEAL VALUES. REMARK 3 RMSD COUNT REMARK 3 BOND : 0.009 5590 REMARK 3 ANGLE : 0.883 7642 REMARK 3 CHIRALITY : 0.059 897 REMARK 3 PLANARITY : 0.006 944 REMARK 3 DIHEDRAL : 13.272 2042 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 NCS DETAILS REMARK 3 NUMBER OF NCS GROUPS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 7A0T COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBE ON 10-AUG-20. REMARK 100 THE DEPOSITION ID IS D_1292110644. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 15-APR-16 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : NULL REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : ESRF REMARK 200 BEAMLINE : ID30B REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.95 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : PIXEL REMARK 200 DETECTOR MANUFACTURER : DECTRIS PILATUS3 6M REMARK 200 INTENSITY-INTEGRATION SOFTWARE : XDS REMARK 200 DATA SCALING SOFTWARE : XDS REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 55149 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.000 REMARK 200 RESOLUTION RANGE LOW (A) : 49.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 99.3 REMARK 200 DATA REDUNDANCY : 5.100 REMARK 200 R MERGE (I) : 0.09800 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 11.5300 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.00 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.07 REMARK 200 COMPLETENESS FOR SHELL (%) : 98.6 REMARK 200 DATA REDUNDANCY IN SHELL : 3.50 REMARK 200 R MERGE FOR SHELL (I) : 0.63500 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: AB INITIO PHASING REMARK 200 SOFTWARE USED: PHASER REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 54.00 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.70 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: JCSG+ 2-31 (0.1 M SUCCINIC ACID, 15% REMARK 280 W/V PEG 3350), VAPOR DIFFUSION, SITTING DROP, TEMPERATURE 289K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 1 21 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 1.000000 0.000000 39.89500 REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, C REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: B, D REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 MET A 1 REMARK 465 ARG A 2 REMARK 465 ALA A 3 REMARK 465 SER A 4 REMARK 465 PHE A 5 REMARK 465 LEU A 6 REMARK 465 LEU A 7 REMARK 465 THR A 8 REMARK 465 ALA A 9 REMARK 465 GLY A 10 REMARK 465 LEU A 11 REMARK 465 ALA A 12 REMARK 465 THR A 13 REMARK 465 ALA A 14 REMARK 465 ALA A 15 REMARK 465 VAL A 16 REMARK 465 GLY A 17 REMARK 465 ARG A 18 REMARK 465 ALA A 19 REMARK 465 LYS A 20 REMARK 465 SER A 21 REMARK 465 VAL A 22 REMARK 465 PRO A 23 REMARK 465 MET B 1 REMARK 465 ARG B 2 REMARK 465 ALA B 3 REMARK 465 SER B 4 REMARK 465 PHE B 5 REMARK 465 LEU B 6 REMARK 465 LEU B 7 REMARK 465 THR B 8 REMARK 465 ALA B 9 REMARK 465 GLY B 10 REMARK 465 LEU B 11 REMARK 465 ALA B 12 REMARK 465 THR B 13 REMARK 465 ALA B 14 REMARK 465 ALA B 15 REMARK 465 VAL B 16 REMARK 465 GLY B 17 REMARK 465 ARG B 18 REMARK 465 ALA B 19 REMARK 465 LYS B 20 REMARK 465 SER B 21 REMARK 465 VAL B 22 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 ND2 ASN B 112 O5 NAG B 501 2.18 REMARK 500 O VAL A 309 O HOH A 701 2.18 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ASN A 39 18.80 56.32 REMARK 500 ASP A 117 84.42 -161.90 REMARK 500 ASN A 122 41.42 -93.00 REMARK 500 LEU A 133 -42.67 -147.31 REMARK 500 PHE A 294 -56.72 -123.83 REMARK 500 ASP B 117 92.09 -163.28 REMARK 500 ASN B 122 49.18 -97.94 REMARK 500 ASN B 132 29.38 43.47 REMARK 500 LEU B 133 -28.85 -153.92 REMARK 500 THR B 154 48.08 -84.20 REMARK 500 ARG B 248 96.79 -163.07 REMARK 500 REMARK 500 REMARK: NULL REMARK 525 REMARK 525 SOLVENT REMARK 525 REMARK 525 THE SOLVENT MOLECULES HAVE CHAIN IDENTIFIERS THAT REMARK 525 INDICATE THE POLYMER CHAIN WITH WHICH THEY ARE MOST REMARK 525 CLOSELY ASSOCIATED. THE REMARK LISTS ALL THE SOLVENT REMARK 525 MOLECULES WHICH ARE MORE THAN 5A AWAY FROM THE REMARK 525 NEAREST POLYMER CHAIN (M = MODEL NUMBER; REMARK 525 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE REMARK 525 NUMBER; I=INSERTION CODE): REMARK 525 REMARK 525 M RES CSSEQI REMARK 525 HOH B 839 DISTANCE = 6.61 ANGSTROMS REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 7A0Q RELATED DB: PDB DBREF 7A0T A 1 348 UNP C7ZKN4 C7ZKN4_NECH7 1 348 DBREF 7A0T B 1 348 UNP C7ZKN4 C7ZKN4_NECH7 1 348 SEQRES 1 A 348 MET ARG ALA SER PHE LEU LEU THR ALA GLY LEU ALA THR SEQRES 2 A 348 ALA ALA VAL GLY ARG ALA LYS SER VAL PRO LYS LYS PHE SEQRES 3 A 348 PRO PHE LYS PRO GLU ASN SER LYS THR THR GLY THR ASN SEQRES 4 A 348 ALA ILE PRO ILE VAL TYR GLY LEU SER GLU SER GLN PRO SEQRES 5 A 348 ASN SER VAL GLY GLY SER TRP TRP SER SER SER TYR ILE SEQRES 6 A 348 THR THR THR ASN ASN GLU GLN TYR VAL VAL LEU ALA HIS SEQRES 7 A 348 TYR LEU ASP ASN PRO VAL TYR THR TYR PHE ARG ALA SER SEQRES 8 A 348 THR LEU ASN LEU GLU THR ASN GLU TYR HIS GLN TYR VAL SEQRES 9 A 348 THR VAL GLY SER SER THR PRO ASN ILE THR THR LEU ASP SEQRES 10 A 348 VAL SER VAL GLY ASN ASN GLY ILE LYS SER GLU SER GLU SEQRES 11 A 348 ASP ASN LEU SER LYS LEU ARG SER TYR SER ASN HIS ASP SEQRES 12 A 348 ASN VAL THR PHE ASP ILE THR TYR ASP ALA THR THR GLY SEQRES 13 A 348 ALA VAL ALA ASN GLY GLY ALA GLY THR PHE GLN PHE GLY SEQRES 14 A 348 GLU GLY LEU THR TRP GLU PHE GLY LEU PRO SER ALA LYS SEQRES 15 A 348 THR GLU GLY SER LEU THR VAL HIS GLY GLU LYS LEU ALA SEQRES 16 A 348 ILE ASP PRO ALA LYS SER HIS THR TRP TYR ASP ARG GLN SEQRES 17 A 348 TRP GLY ASN THR ALA ALA ILE PRO SER ASN TRP THR TRP SEQRES 18 A 348 PHE GLN LEU HIS ILE PRO SER THR GLU TYR LYS ILE SER SEQRES 19 A 348 ALA TRP ILE PHE SER ASP PRO PHE ARG ASN THR GLU THR SEQRES 20 A 348 ARG PHE ALA THR ILE ARG GLY ALA ASN ASP GLU THR LEU SEQRES 21 A 348 VAL LEU PRO LEU GLU PHE THR PRO ILE TYR LYS ARG THR SEQRES 22 A 348 TYR GLU SER ALA THR GLY ARG VAL THR TYR PRO LEU ASP SEQRES 23 A 348 TRP LYS LEU LYS ILE SER GLY PHE GLY ASP PHE LYS LEU SEQRES 24 A 348 SER SER TYR THR GLU ASP GLN GLU LEU VAL GLY GLU ASP SEQRES 25 A 348 ALA LEU GLN THR ALA TYR GLU GLY PHE ILE THR PHE SER SEQRES 26 A 348 GLY ASN VAL HIS SER LYS PRO VAL GLN GLY TYR GLY LEU SEQRES 27 A 348 VAL GLU ILE VAL TYR SER THR TRP ASP VAL SEQRES 1 B 348 MET ARG ALA SER PHE LEU LEU THR ALA GLY LEU ALA THR SEQRES 2 B 348 ALA ALA VAL GLY ARG ALA LYS SER VAL PRO LYS LYS PHE SEQRES 3 B 348 PRO PHE LYS PRO GLU ASN SER LYS THR THR GLY THR ASN SEQRES 4 B 348 ALA ILE PRO ILE VAL TYR GLY LEU SER GLU SER GLN PRO SEQRES 5 B 348 ASN SER VAL GLY GLY SER TRP TRP SER SER SER TYR ILE SEQRES 6 B 348 THR THR THR ASN ASN GLU GLN TYR VAL VAL LEU ALA HIS SEQRES 7 B 348 TYR LEU ASP ASN PRO VAL TYR THR TYR PHE ARG ALA SER SEQRES 8 B 348 THR LEU ASN LEU GLU THR ASN GLU TYR HIS GLN TYR VAL SEQRES 9 B 348 THR VAL GLY SER SER THR PRO ASN ILE THR THR LEU ASP SEQRES 10 B 348 VAL SER VAL GLY ASN ASN GLY ILE LYS SER GLU SER GLU SEQRES 11 B 348 ASP ASN LEU SER LYS LEU ARG SER TYR SER ASN HIS ASP SEQRES 12 B 348 ASN VAL THR PHE ASP ILE THR TYR ASP ALA THR THR GLY SEQRES 13 B 348 ALA VAL ALA ASN GLY GLY ALA GLY THR PHE GLN PHE GLY SEQRES 14 B 348 GLU GLY LEU THR TRP GLU PHE GLY LEU PRO SER ALA LYS SEQRES 15 B 348 THR GLU GLY SER LEU THR VAL HIS GLY GLU LYS LEU ALA SEQRES 16 B 348 ILE ASP PRO ALA LYS SER HIS THR TRP TYR ASP ARG GLN SEQRES 17 B 348 TRP GLY ASN THR ALA ALA ILE PRO SER ASN TRP THR TRP SEQRES 18 B 348 PHE GLN LEU HIS ILE PRO SER THR GLU TYR LYS ILE SER SEQRES 19 B 348 ALA TRP ILE PHE SER ASP PRO PHE ARG ASN THR GLU THR SEQRES 20 B 348 ARG PHE ALA THR ILE ARG GLY ALA ASN ASP GLU THR LEU SEQRES 21 B 348 VAL LEU PRO LEU GLU PHE THR PRO ILE TYR LYS ARG THR SEQRES 22 B 348 TYR GLU SER ALA THR GLY ARG VAL THR TYR PRO LEU ASP SEQRES 23 B 348 TRP LYS LEU LYS ILE SER GLY PHE GLY ASP PHE LYS LEU SEQRES 24 B 348 SER SER TYR THR GLU ASP GLN GLU LEU VAL GLY GLU ASP SEQRES 25 B 348 ALA LEU GLN THR ALA TYR GLU GLY PHE ILE THR PHE SER SEQRES 26 B 348 GLY ASN VAL HIS SER LYS PRO VAL GLN GLY TYR GLY LEU SEQRES 27 B 348 VAL GLU ILE VAL TYR SER THR TRP ASP VAL HET NAG C 1 14 HET NAG C 2 14 HET BMA C 3 11 HET MAN C 4 11 HET MAN C 5 11 HET MAN C 6 11 HET MAN C 7 11 HET MAN C 8 11 HET MAN C 9 11 HET MAN C 10 11 HET NAG D 1 14 HET NAG D 2 14 HET BMA D 3 11 HET MAN D 4 11 HET MAN D 5 11 HET MAN D 6 11 HET MAN D 7 11 HET MAN D 8 11 HET MAN D 9 11 HET MAN D 10 11 HET IMD A 601 5 HET NAG B 501 14 HET IMD B 502 5 HETNAM NAG 2-ACETAMIDO-2-DEOXY-BETA-D-GLUCOPYRANOSE HETNAM BMA BETA-D-MANNOPYRANOSE HETNAM MAN ALPHA-D-MANNOPYRANOSE HETNAM IMD IMIDAZOLE HETSYN NAG N-ACETYL-BETA-D-GLUCOSAMINE; 2-ACETAMIDO-2-DEOXY-BETA- HETSYN 2 NAG D-GLUCOSE; 2-ACETAMIDO-2-DEOXY-D-GLUCOSE; 2-ACETAMIDO- HETSYN 3 NAG 2-DEOXY-GLUCOSE; N-ACETYL-D-GLUCOSAMINE HETSYN BMA BETA-D-MANNOSE; D-MANNOSE; MANNOSE HETSYN MAN ALPHA-D-MANNOSE; D-MANNOSE; MANNOSE FORMUL 3 NAG 5(C8 H15 N O6) FORMUL 3 BMA 2(C6 H12 O6) FORMUL 3 MAN 14(C6 H12 O6) FORMUL 5 IMD 2(C3 H5 N2 1+) FORMUL 8 HOH *432(H2 O) HELIX 1 AA1 GLY A 46 GLN A 51 1 6 HELIX 2 AA2 PRO A 52 GLY A 56 5 5 HELIX 3 AA3 ASP A 197 SER A 201 5 5 HELIX 4 AA4 LEU B 47 GLN B 51 5 5 HELIX 5 AA5 PRO B 52 GLY B 56 5 5 HELIX 6 AA6 ASP B 197 SER B 201 5 5 HELIX 7 1 LEU A 47 SER A 50 1 4 HELIX 8 2 ASN A 53 VAL A 55 5 3 HELIX 9 3 PRO A 198 LYS A 200 5 3 HELIX 10 4 SER B 48 SER B 50 5 3 HELIX 11 5 ASN B 53 VAL B 55 5 3 HELIX 12 6 PRO B 198 LYS B 200 5 3 SHEET 1 A 7 ALA A 157 ALA A 159 0 SHEET 2 A 7 THR A 173 LEU A 178 -1 SHEET 3 A 7 HIS A 202 GLY A 210 -1 SHEET 4 A 7 SER A 58 THR A 66 -1 SHEET 5 A 7 GLN A 72 ASP A 81 -1 SHEET 6 A 7 THR A 86 ASN A 94 -1 SHEET 7 A 7 TYR A 100 GLY A 107 -1 SHEET 1 B 6 ASP A 117 SER A 119 0 SHEET 2 B 6 GLY A 124 SER A 127 -1 SHEET 3 B 6 LYS A 135 ASN A 141 -1 SHEET 4 B 6 THR A 146 ASP A 152 -1 SHEET 5 B 6 LYS A 182 VAL A 189 -1 SHEET 6 B 6 GLU A 192 ALA A 195 -1 SHEET 1 C 2 THR A 165 PHE A 168 0 SHEET 2 C 2 GLY A 171 TRP A 174 -1 SHEET 1 D 9 THR A 259 PRO A 263 0 SHEET 2 D 9 THR A 245 ARG A 253 -1 SHEET 3 D 9 LYS A 232 ASP A 240 -1 SHEET 4 D 9 ASN A 218 HIS A 225 -1 SHEET 5 D 9 LYS A 331 TYR A 343 -1 SHEET 6 D 9 TYR A 318 VAL A 328 -1 SHEET 7 D 9 GLY A 295 SER A 301 -1 SHEET 8 D 9 ASP A 286 ILE A 291 -1 SHEET 9 D 9 LEU A 264 ILE A 269 -1 SHEET 1 E 2 THR A 273 GLU A 275 0 SHEET 2 E 2 THR A 282 PRO A 284 -1 SHEET 1 F 7 ALA B 157 ALA B 159 0 SHEET 2 F 7 THR B 173 LEU B 178 -1 SHEET 3 F 7 HIS B 202 GLY B 210 -1 SHEET 4 F 7 SER B 58 THR B 66 -1 SHEET 5 F 7 GLN B 72 ASP B 81 -1 SHEET 6 F 7 THR B 86 ASN B 94 -1 SHEET 7 F 7 TYR B 100 GLY B 107 -1 SHEET 1 G 6 ASP B 117 VAL B 120 0 SHEET 2 G 6 ASN B 123 SER B 127 -1 SHEET 3 G 6 LEU B 136 ASN B 141 -1 SHEET 4 G 6 THR B 146 ASP B 152 -1 SHEET 5 G 6 LYS B 182 VAL B 189 -1 SHEET 6 G 6 GLU B 192 ALA B 195 -1 SHEET 1 H 2 THR B 165 PHE B 168 0 SHEET 2 H 2 GLY B 171 TRP B 174 -1 SHEET 1 I 9 THR B 259 PRO B 263 0 SHEET 2 I 9 THR B 245 ARG B 253 -1 SHEET 3 I 9 LYS B 232 ASP B 240 -1 SHEET 4 I 9 ASN B 218 HIS B 225 -1 SHEET 5 I 9 LYS B 331 TYR B 343 -1 SHEET 6 I 9 TYR B 318 VAL B 328 -1 SHEET 7 I 9 GLY B 295 SER B 301 -1 SHEET 8 I 9 ASP B 286 ILE B 291 -1 SHEET 9 I 9 LEU B 264 ILE B 269 -1 SHEET 1 J 2 THR B 273 GLU B 275 0 SHEET 2 J 2 THR B 282 PRO B 284 -1 LINK ND2 ASN A 218 C1 NAG C 1 1555 1555 1.46 LINK ND2 ASN B 112 C1 NAG B 501 1555 1555 1.43 LINK ND2 ASN B 218 C1 NAG D 1 1555 1555 1.44 LINK O4 NAG C 1 C1 NAG C 2 1555 1555 1.43 LINK O4 NAG C 2 C1 BMA C 3 1555 1555 1.43 LINK O3 BMA C 3 C1 MAN C 4 1555 1555 1.44 LINK O6 BMA C 3 C1 MAN C 7 1555 1555 1.44 LINK O2 MAN C 4 C1 MAN C 5 1555 1555 1.44 LINK O2 MAN C 5 C1 MAN C 6 1555 1555 1.44 LINK O6 MAN C 7 C1 MAN C 8 1555 1555 1.44 LINK O3 MAN C 7 C1 MAN C 10 1555 1555 1.44 LINK O2 MAN C 8 C1 MAN C 9 1555 1555 1.45 LINK O4 NAG D 1 C1 NAG D 2 1555 1555 1.44 LINK O4 NAG D 2 C1 BMA D 3 1555 1555 1.44 LINK O3 BMA D 3 C1 MAN D 4 1555 1555 1.44 LINK O6 BMA D 3 C1 MAN D 7 1555 1555 1.44 LINK O2 MAN D 4 C1 MAN D 5 1555 1555 1.44 LINK O2 MAN D 5 C1 MAN D 6 1555 1555 1.44 LINK O6 MAN D 7 C1 MAN D 8 1555 1555 1.44 LINK O3 MAN D 7 C1 MAN D 10 1555 1555 1.45 LINK O2 MAN D 8 C1 MAN D 9 1555 1555 1.44 CRYST1 51.430 79.790 103.180 90.00 100.68 90.00 P 1 21 1 4 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.019444 0.000000 0.003667 0.00000 SCALE2 0.000000 0.012533 0.000000 0.00000 SCALE3 0.000000 0.000000 0.009863 0.00000